24
Participants
Start Date
June 1, 2025
Primary Completion Date
July 30, 2025
Study Completion Date
August 30, 2025
R1_PBK_M2301(Levocloperastine 60mg)
R1\_PBK\_M2301 is a test drug containing 60mg of levocloperastine per tablet. It is administered orally to evaluate pharmacokinetic characteristics and potential drug-drug interactions with R2\_PBK\_M2301 in healthy adult volunteers.
R2_PBK_M2301 (Pelargonium sidoides extract)
R2\_PBK\_M2301 is an oral tablet containing 20 mg of Pelargonium sidoides 11% ethanol extract, used as a comparator to evaluate potential pharmacokinetic interactions with R1\_PBK\_M2301.
H+ Yangji Hospital, Seoul
Lead Sponsor
Pharmbio Korea Co., Ltd.
INDUSTRY